05635nam 2200673 450 991078654660332120230803034900.01-59756-641-1(CKB)3710000000122048(EBL)1886741(SSID)ssj0001261333(PQKBManifestationID)11694218(PQKBTitleCode)TC0001261333(PQKBWorkID)11320753(PQKB)11241036(MiAaPQ)EBC1886741(Au-PeEL)EBL1886741(CaPaEBR)ebr10901621(OCoLC)885279152(EXLCZ)99371000000012204820140813h20132013 uy 0engur|n|---|||||txtrdacontentcrdamediacrrdacarrierMCI and Alzheimer's dementia clinical essentials for assessment and treatment of cognitive-communication disorders /Kathryn A. Bayles, Cheryl K. Tomoeda ; Kimberly C. McCullough, contributorSan Diego, California :Plural Publishing, Inc.,2013.©20131 online resource (xix, 209 pages) illustrationsDescription based upon print version of record.1-59756-518-0 Includes bibliographical references at the end of each chapters and index.Contents; Preface; Introduction; Acknowledgments; Contributors; Unit 1: Cognition, Memory, and Communication; Cognition and Memory; The "Company of Cognition"; Memory Defined; Sensory Memory; Working Memory; Long-Term Memory; Relation of Cognition and Memory to Communication; Production of Linguistic Information; Comprehension of Linguistic Information; Summary of Important Points; References; Unit 2: MCI: Minimal Cognitive Impairment; Mild Cognitive Impairment; Clinical Presentations of MCI; Prevalence of MCI in the Population; Diagnostic Criteria for MCI and AD; Conversion to DementiaConversion Rate by MCI SubtypeNumber of Deficits and Conversion to Dementia; Risk and Protective Factors; Cognitive Deficits; Cognitive-Linguistic Deficits; Type of Language Changes; Summary; Summary of Important Points; References; Unit 3: Alzheimer's Dementia; Alzheimer's Disease; Diagnostic Criteria for AD; Neuropathology of AD; Risk Factors for AD; Age; Family History of AD; Less Education; History of Head Trauma; Loneliness; Gender; Maternal Age; Apolipoprotein E4 Allele; Minimal Cognitive Impairment; Predictors of Disease Progression; Protective FactorsEffects of AD on Cognitive and Communicative FunctionsEarly Stage; Middle Stage; Late-Stage AD; Summary of Important Points; References; Unit 4: Assessment of Cognitive-Communicative Function in Minimal Cognitive Impairment and Alzheimer's Dementia; Role of the Speech-Language Pathologist; The Process of Assessment; Prior to Testing; Review Medical History; Secure a Quiet, Well-Lit Test Environment; Testing; Check Vision; Check Hearing; Check Literacy; Be Alert to Depression; Be Alert to Adverse Drug Effects on Performance; Use Appropriate Tests; Assessment of MCI Due to AD; Screening for MCIComprehensive Neuropsychological Approach to ScreeningAssessment of AD; Screening for AD; Comprehensive Assessment of AD; Summary of Important Points; References; Unit 5: Rationale for Therapy; Neuroplasticity; Memory Systems and Their Vulnerability to AD Pathology; Cognitive Reserve; Cognitive Stimulation Therapy Can Build Cognitive Reserve; Summary of Important Points; References; Unit 6: Cognitive Intervention and Minimal Cognitive Impairment; Different Forms of Cognitive Intervention Used in Individuals with MCI; Key Element 1: Base repetition focus on cognitive domainsComputer-Based TrainingKey Element 2: Provide direct training of strategies and functional skills.; Key Element 3: Empower clients with education regarding healthy aging and brain habits.; Key Element 4: Include opportunities for social engagement.; Conclusion; Summary of Important Points; References; Unit 7: Treatment: Direct Interventions; Definitions; Treatment Guidelines; Strategies for Successful Intervention; Facilitating Perception; Consider Span Capacity of Working Memory; Control of Task Complexity; Minimize Error Responses; Recognition Is Easier Than RecallUse Retrieval Cues That Reflect Support Given at EncodingThis book succinctly presents critical information about the cognitive-communicative disorders associated with mild cognitive impairment (MCI) and Alzheimer's disease (AD). It includes cutting-edge information about MCI, a very early stage of Alzheimer's disease, and the role of speech-language pathologists (SLPs) in early identification and behavioral and/or pharmacologic treatments. Clinical essentials-definitions, assessments, and treatments-for MCI and AD are also covered.Alzheimer's diseaseDiagnosisAlzheimer's diseaseTreatmentMild cognitive impairmentDiagnosisMild cognitive impairmentTreatmentAlzheimer's diseaseDiagnosis.Alzheimer's diseaseTreatment.Mild cognitive impairmentDiagnosis.Mild cognitive impairmentTreatment.616.8/31Bayles Kathryn A.1942-1498961Tomoeda Cheryl K.McCullough Kimberly C.MiAaPQMiAaPQMiAaPQBOOK9910786546603321MCI and Alzheimer's dementia3724745UNINA